메뉴 건너뛰기




Volumn 15, Issue 1, 2014, Pages 111-119

Do low levels of beta-endorphin in the cerebrospinal fluid indicate defective top-down inhibition in patients with chronic neuropathic pain? A cross-sectional, comparative study

Author keywords

Beta endorphin; Biomarker; Cerebrospinal fluid; Neuropathic; Pain; Substance P

Indexed keywords

BETA ENDORPHIN; BIOLOGICAL MARKER; SUBSTANCE P;

EID: 84892490621     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/pme.12248     Document Type: Article
Times cited : (27)

References (40)
  • 2
    • 84860600115 scopus 로고    scopus 로고
    • Abnormal endogenous pain modulation is a shared characteristic of many chronic pain conditions
    • Staud R. Abnormal endogenous pain modulation is a shared characteristic of many chronic pain conditions. Expert Rev Neurother 2012;12:577-585.
    • (2012) Expert Rev Neurother , vol.12 , pp. 577-585
    • Staud, R.1
  • 3
    • 63449092750 scopus 로고    scopus 로고
    • Descending control of nociception: Specificity, recruitment and plasticity
    • Heinricher MM, Tavares I, Leith JL, Lumb BM. Descending control of nociception: Specificity, recruitment and plasticity. Brain Res Rev. 2009;60:214-225.
    • (2009) Brain Res Rev. , vol.60 , pp. 214-225
    • Heinricher, M.M.1    Tavares, I.2    Leith, J.L.3    Lumb, B.M.4
  • 4
    • 84868542805 scopus 로고    scopus 로고
    • Basic opioid pharmacology: An update
    • Pathan H, Williams J. Basic opioid pharmacology: An update. Br J Pain 2012;6:11-16.
    • (2012) Br J Pain , vol.6 , pp. 11-16
    • Pathan, H.1    Williams, J.2
  • 5
    • 33750630238 scopus 로고    scopus 로고
    • Noradrenergic pain modulation
    • Pertovaara A. Noradrenergic pain modulation. Prog Neurobiol 2006;80:53-83.
    • (2006) Prog Neurobiol , vol.80 , pp. 53-83
    • Pertovaara, A.1
  • 6
    • 77951623401 scopus 로고    scopus 로고
    • Perspective on diffuse noxious inhibitory controls as a model of endogenous pain modulation in clinical pain syndromes
    • van Wijk G, Veldhuijzen DS. Perspective on diffuse noxious inhibitory controls as a model of endogenous pain modulation in clinical pain syndromes. J Pain 2010;11:408-419.
    • (2010) J Pain , vol.11 , pp. 408-419
    • van Wijk, G.1    Veldhuijzen, D.S.2
  • 7
    • 0013851199 scopus 로고
    • Pain mechanisms: A new theory
    • Melzack R, Wall PD. Pain mechanisms: A new theory. Science 1965;150:971-979.
    • (1965) Science , vol.150 , pp. 971-979
    • Melzack, R.1    Wall, P.D.2
  • 8
    • 79960149270 scopus 로고    scopus 로고
    • Biomarkers for chronic pain and analgesia. Part 1: The need, reality, challenges, and solutions
    • Borsook D, Becerra L, Hargreaves R. Biomarkers for chronic pain and analgesia. Part 1: The need, reality, challenges, and solutions. Discov Med 2011;11:197-207.
    • (2011) Discov Med , vol.11 , pp. 197-207
    • Borsook, D.1    Becerra, L.2    Hargreaves, R.3
  • 9
    • 1842452956 scopus 로고    scopus 로고
    • Biomarkers for pain
    • Kalso E. Biomarkers for pain. Pain 2004;107:199-201.
    • (2004) Pain , vol.107 , pp. 199-201
    • Kalso, E.1
  • 11
    • 41149090715 scopus 로고    scopus 로고
    • Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers
    • Roche S, Gabelle A, Lehmann S. Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers. Proteomics Clin Appl 2008;2:428-436.
    • (2008) Proteomics Clin Appl , vol.2 , pp. 428-436
    • Roche, S.1    Gabelle, A.2    Lehmann, S.3
  • 12
    • 84862242457 scopus 로고    scopus 로고
    • [Pain and consciousness mocks philosophers and scientists]
    • Bäckryd E. [Pain and consciousness mocks philosophers and scientists]. Lakartidningen 2012;109:1039-1040.
    • (2012) Lakartidningen , vol.109 , pp. 1039-1040
    • Bäckryd, E.1
  • 13
    • 1542268262 scopus 로고    scopus 로고
    • Pain: Moving from symptom control toward mechanism-specific pharmacologic management
    • Woolf CJ. Pain: Moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med 2004;140:441-451.
    • (2004) Ann Intern Med , vol.140 , pp. 441-451
    • Woolf, C.J.1
  • 14
    • 0024253671 scopus 로고
    • Cerebrospinal fluid levels of beta-endorphin in patients with fibromyalgia (fibrositis syndrome)
    • Vaeroy H, Helle R, Forre O, Kass E, Terenius L. Cerebrospinal fluid levels of beta-endorphin in patients with fibromyalgia (fibrositis syndrome). J Rheumatol 1988;15:1804-1806.
    • (1988) J Rheumatol , vol.15 , pp. 1804-1806
    • Vaeroy, H.1    Helle, R.2    Forre, O.3    Kass, E.4    Terenius, L.5
  • 15
    • 84866165807 scopus 로고    scopus 로고
    • Volume transmission of beta-endorphin via the cerebrospinal fluid; a review
    • Veening JG, Gerrits PO, Barendregt HP. Volume transmission of beta-endorphin via the cerebrospinal fluid; a review. Fluids Barriers CNS 2012;9:16.
    • (2012) Fluids Barriers CNS , vol.9 , pp. 16
    • Veening, J.G.1    Gerrits, P.O.2    Barendregt, H.P.3
  • 16
    • 0038714965 scopus 로고    scopus 로고
    • Neuropeptides: Opportunities for drug discovery
    • Hokfelt T, Bartfai T, Bloom F. Neuropeptides: Opportunities for drug discovery. Lancet Neurol 2003;2:463-472.
    • (2003) Lancet Neurol , vol.2 , pp. 463-472
    • Hokfelt, T.1    Bartfai, T.2    Bloom, F.3
  • 18
    • 0037109674 scopus 로고    scopus 로고
    • Spinal neurons that possess the substance P receptor are required for the development of central sensitization
    • Khasabov SG, Rogers SD, Ghilardi JR, etal. Spinal neurons that possess the substance P receptor are required for the development of central sensitization. J Neurosci 2002;22:9086-9098.
    • (2002) J Neurosci , vol.22 , pp. 9086-9098
    • Khasabov, S.G.1    Rogers, S.D.2    Ghilardi, J.R.3
  • 19
    • 0028104819 scopus 로고
    • Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome
    • Russell IJ, Orr MD, Littman B, etal. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994;37:1593-1601.
    • (1994) Arthritis Rheum , vol.37 , pp. 1593-1601
    • Russell, I.J.1    Orr, M.D.2    Littman, B.3
  • 20
    • 0023919037 scopus 로고
    • Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: New features for diagnosis
    • Vaeroy H, Helle R, Forre O, Kass E, Terenius L. Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: New features for diagnosis. Pain 1988;32:21-26.
    • (1988) Pain , vol.32 , pp. 21-26
    • Vaeroy, H.1    Helle, R.2    Forre, O.3    Kass, E.4    Terenius, L.5
  • 21
    • 84861222902 scopus 로고    scopus 로고
    • Between Metabolite Relationships: An essential aspect of metabolic change
    • Jansen JJ, Szymanska E, Hoefsloot HC, etal. Between Metabolite Relationships: An essential aspect of metabolic change. Metabolomics 2012;8:422-432.
    • (2012) Metabolomics , vol.8 , pp. 422-432
    • Jansen, J.J.1    Szymanska, E.2    Hoefsloot, H.C.3
  • 22
    • 34347250900 scopus 로고    scopus 로고
    • A multivariate screening strategy for investigating metabolic effects of strenuous physical exercise in human serum
    • Pohjanen E, Thysell E, Jonsson P, etal. A multivariate screening strategy for investigating metabolic effects of strenuous physical exercise in human serum. J Proteome Res 2007;6:2113-2120.
    • (2007) J Proteome Res , vol.6 , pp. 2113-2120
    • Pohjanen, E.1    Thysell, E.2    Jonsson, P.3
  • 24
    • 0018103950 scopus 로고
    • Endorphins in chronic pain. I. Differences in CSF endorphin levels between organic and psychogenic pain syndromes
    • Almay BG, Johansson F, Von Knorring L, Terenius L, Wahlstrom A. Endorphins in chronic pain. I. Differences in CSF endorphin levels between organic and psychogenic pain syndromes. Pain 1978;5:153-162.
    • (1978) Pain , vol.5 , pp. 153-162
    • Almay, B.G.1    Johansson, F.2    Von Knorring, L.3    Terenius, L.4    Wahlstrom, A.5
  • 25
    • 84940141191 scopus 로고
    • Investigation on cerebrospinal fluid opioids and neurotransmitters related to spinal cord stimulation
    • Tonelli L, Setti T, Falasca A, etal. Investigation on cerebrospinal fluid opioids and neurotransmitters related to spinal cord stimulation. Appl Neurophysiol 1988;51:324-332.
    • (1988) Appl Neurophysiol , vol.51 , pp. 324-332
    • Tonelli, L.1    Setti, T.2    Falasca, A.3
  • 26
    • 0026770981 scopus 로고
    • Effects of dorsal root entry zone lesions on CSF and plasma neuropeptides and catecholamines
    • Fujiwara N, Shimoji K, Kumagai Y, Endoh H, Fukuda S. Effects of dorsal root entry zone lesions on CSF and plasma neuropeptides and catecholamines. Acta Neurochir (Wien) 1992;117:38-43.
    • (1992) Acta Neurochir (Wien) , vol.117 , pp. 38-43
    • Fujiwara, N.1    Shimoji, K.2    Kumagai, Y.3    Endoh, H.4    Fukuda, S.5
  • 27
    • 0021048826 scopus 로고
    • Different patterns of central and peripheral beta EP, beta LPH and ACTH throughout life
    • Facchinetti F, Nappi G, Martignoni E, etal. Different patterns of central and peripheral beta EP, beta LPH and ACTH throughout life. Peptides 1983;4:469-474.
    • (1983) Peptides , vol.4 , pp. 469-474
    • Facchinetti, F.1    Nappi, G.2    Martignoni, E.3
  • 28
    • 0026871251 scopus 로고
    • Radioimmunoassay of beta-endorphin in ventricular and lumbar cerebrospinal fluid
    • Bach FW, Schmidt JF, Faber T. Radioimmunoassay of beta-endorphin in ventricular and lumbar cerebrospinal fluid. Clin Chem 1992;38:847-852.
    • (1992) Clin Chem , vol.38 , pp. 847-852
    • Bach, F.W.1    Schmidt, J.F.2    Faber, T.3
  • 29
    • 0031952573 scopus 로고    scopus 로고
    • Age-related changes in the cerebrospinal fluid level of beta-endorphin and substance P. Short communication
    • Nagamitsu S, Matsuishi T, Komori H, etal. Age-related changes in the cerebrospinal fluid level of beta-endorphin and substance P. Short communication. J Neural Transm 1998;105:53-58.
    • (1998) J Neural Transm , vol.105 , pp. 53-58
    • Nagamitsu, S.1    Matsuishi, T.2    Komori, H.3
  • 31
    • 84874969868 scopus 로고    scopus 로고
    • What do plasma beta-endorphin levels reveal about endogenous opioid analgesic function?
    • Bruehl S, Burns JW, Chung OY, Chont M. What do plasma beta-endorphin levels reveal about endogenous opioid analgesic function? Eur J Pain 2012;16:370-380.
    • (2012) Eur J Pain , vol.16 , pp. 370-380
    • Bruehl, S.1    Burns, J.W.2    Chung, O.Y.3    Chont, M.4
  • 33
    • 0031450220 scopus 로고    scopus 로고
    • Elevated cerebrospinal fluid substance P-like immunoreactivity in patients with painful osteoarthritis, but not in patients with rhizopatic pain from a herniated lumbar disc
    • Lindh C, Liu Z, Lyrenas S, Ordeberg G, Nyberg F. Elevated cerebrospinal fluid substance P-like immunoreactivity in patients with painful osteoarthritis, but not in patients with rhizopatic pain from a herniated lumbar disc. Scand J Rheumatol 1997;26:468-472.
    • (1997) Scand J Rheumatol , vol.26 , pp. 468-472
    • Lindh, C.1    Liu, Z.2    Lyrenas, S.3    Ordeberg, G.4    Nyberg, F.5
  • 34
    • 0029843327 scopus 로고    scopus 로고
    • [Substance P, somatostatin and monoaminergic transmitters in the cerebrospinal fluid of patients with chronic idiopathic trigeminal neuralgia]
    • Strittmatter M, Grauer M, Isenberg E, etal. [Substance P, somatostatin and monoaminergic transmitters in the cerebrospinal fluid of patients with chronic idiopathic trigeminal neuralgia]. Schmerz 1996;10:261-268.
    • (1996) Schmerz , vol.10 , pp. 261-268
    • Strittmatter, M.1    Grauer, M.2    Isenberg, E.3
  • 35
    • 0031772214 scopus 로고    scopus 로고
    • Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome
    • Evengard B, Nilsson CG, Lindh G, etal. Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome. Pain 1998;78:153-155.
    • (1998) Pain , vol.78 , pp. 153-155
    • Evengard, B.1    Nilsson, C.G.2    Lindh, G.3
  • 36
    • 84877644805 scopus 로고    scopus 로고
    • A potential role for substance P and interleukin-6 in the cerebrospinal fluid of Cavalier King Charles Spaniels with neuropathic pain
    • Schmidt MJ, Roth J, Ondreka N, Kramer M, Rummel C. A potential role for substance P and interleukin-6 in the cerebrospinal fluid of Cavalier King Charles Spaniels with neuropathic pain. J Vet Intern Med 2013;27:530-535.
    • (2013) J Vet Intern Med , vol.27 , pp. 530-535
    • Schmidt, M.J.1    Roth, J.2    Ondreka, N.3    Kramer, M.4    Rummel, C.5
  • 37
    • 77954877647 scopus 로고    scopus 로고
    • The role of glia and the immune system in the development and maintenance of neuropathic pain
    • Vallejo R, Tilley DM, Vogel L, Benyamin R. The role of glia and the immune system in the development and maintenance of neuropathic pain. Pain Pract 2010;10:167-184.
    • (2010) Pain Pract , vol.10 , pp. 167-184
    • Vallejo, R.1    Tilley, D.M.2    Vogel, L.3    Benyamin, R.4
  • 38
    • 84882559726 scopus 로고    scopus 로고
    • Mechanisms of glial activation after nerve injury
    • Basbaum AI, Bushnell C, eds. Oxford, UK & San Diego, CA: Elsevier
    • Watkins LR, Milligan ED, Maier SF. Mechanisms of glial activation after nerve injury. In: Basbaum AI, Bushnell C, eds. Science of Pain. Oxford, UK & San Diego, CA: Elsevier; 2009:429-433.
    • (2009) Science of Pain , pp. 429-433
    • Watkins, L.R.1    Milligan, E.D.2    Maier, S.F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.